APOB and cardiovascular disorder: To ascertain the impact of food therapy on the reduction of cardiovascular disease risk at varying baseline levels of ApoB, the food therapy group was subdivided into an ApoB high-baseline group (>100 mg/dL) and an ApoB low-baseline group (<100 mg/dL).